Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content
PHARMACEUTICAL

K-Pack™II

Needles

Description

K-Pack™ II Needles

K-Pack™ II Needles are carefully crafted to achieve smoother injections of today and tomorrow’s parenteral medications – targeting on a less painful injection and thus on higher therapeutic adherence and compliance.

Characteristics

Designed to suit your individual drug needs​


Developed to meet the needs of patients and drug developers, K-Pack™ II Needles are precisely designed with the aim to reduce penetration resistance. 

Designed for subcutaneous, intra-muscular and intravenous injections, K-Pack™ II needles offer the compatibility, quality and supply reliability needed to meet parenteral delivery challenges and product commercialization goals. 

 
Patient's comfort in mind

  • T-Sharp™ technology
  • Silicon coating for smoother, low drag forces during insertions
  • Thin, extra-thin, and ultra-thin-wall cannulas targeted to address reduction of extrusion forces and increase of flow rates even for high drug viscosities1.


Engineered for automated environments

  • Individually packed in ergonomically formed hard-plastic case for automated needle handling and assembly
  • Color-coded tamper-evident label with 2D barcode (UDI-carrier) for 3600 in-line vision inspection
  • Sterilized and ready for controlled environment manufacturing
  • Rounded container design for faster automated pick-and-place assembly routines 

Regulatory and Quality Aspects

  • Ethylene oxide sterilization Sterility Assurance Level at least 10-6
  • In compliance with applicable ISO standards and European Pharmacopoeia 
  • CE certified: CE 0197, Certifying (Notified) Body: TÜV Rheinland LGA Products GmbH, German
  • FDA-cleared
  • Proven track record of reliable supply assured by global operating company

General specifications

​​K-Pack™​ II Needles are intended for subcutaneous, intramuscular an​d intravenous applications.

Specification Description
Needle PointT-SharpTM Triple-bevel lancet point
CannulasStainless steel X5CrNi 18-10
HubPolypropylene + Color Masterbatch
Individual packagingRigid polypropylene
Shipping carton
(standard, other packaging configurations possible)
5000 pcs​
SterilizationEthylene Oxide
Shelf-life5 years

Global Solutions

K-Pack™ II Needle solutions are available to drug product manufacturers globally. For more information about product availability, specifications, and applicable standards, download our data sheet or contact your Terumo representative today.

Please note that some products may not be available in all regions, reach out to your local Terumo Medical Care Solutions - Pharmaceutical Solutions Division contact for details. All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties.


Downloads

Relevant product information
K-Pack II Leaflet_TMCS_2023

References

​1 Data on file​

Let’s Find Your Best Solution

Innovation and creativity are central to our Pharmaceutical Solutions Division value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.

Contact Us

Didn't find your product?

Consult our products in our Product Index

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.